ESCC
Clinical trials for ESCC explained in plain language.
Never miss a new study
Get alerted when new ESCC trials appear
Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink esophageal tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of immunotherapy and chemotherapy, followed by chemoradiation, before surgery can improve outcomes for people with locally advanced esophageal cancer. The goal is to shrink the tumor and reduce the chance of the cancer coming back. Ab…
Matched conditions: ESCC
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated May 17, 2026 03:58 UTC
-
New targeted drug ALX2004 enters first human trials for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called ALX2004 in people with advanced or metastatic solid tumors (lung, head and neck, colorectal, esophageal) that have not responded to standard treatments. ALX2004 is an antibody drug conjugate designed to deliver chemotherapy directly …
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for tough cancers: experimental drug JAB-8263 enters human trials
Disease control Recruiting nowThis study tests a new drug called JAB-8263 in adults with advanced solid tumors (like lung or ovarian cancer) or blood cancers (like leukemia) that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 15…
Matched conditions: ESCC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug NRM-823 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called NRM-823, alone or with an immunotherapy, in 150 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. The study includes several cancer types lik…
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: Normunity AccelCo, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New blood test could spot deadly esophageal cancer before It's too late
Diagnosis Recruiting nowThis study is working on a new blood test to find esophageal cancer at an early, more treatable stage. Current methods like endoscopy are invasive and often miss early signs. The test looks for tiny genetic particles in the blood that are released by cancer cells. Researchers wil…
Matched conditions: ESCC
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 17, 2026 03:55 UTC